Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,520.36
(
0.00%
)
US TECH 100
29,080.00
(
-0.34%
)
Dow Jones
50,644.28
(
0.00%
)
Brent Oil
94.13
(
1.83%
)
Bitcoin
73,372.01
(
-2.03%
)
News Focus
News Focus
Post# of 71
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

peewee

Send PM Follow Ignore
Followers 116
Posts 33453
Boards Moderated 3
Alias Born 10/22/2007

peewee

Re: None

Friday, 06/04/2010 6:53:10 AM

Friday, June 04, 2010 6:53:10 AM

Post# of 71
FDAnews Drug Daily Bulletin
June 4, 2010 | Vol. 7 No. 109

Antisoma’s AS1413 Gains FDA Fast Track Status for Myeloid Leukemia
Cancer drug developer Antisoma Thursday announced that the FDA has granted Fast Track designation to the Company’s novel DNA intercalator, AS1413 (amonafide L-malate), for the treatment of secondary acute myeloid leukemia.



http://www.fdanews.com/newsletter/article?issueId=13751&articleId=127580


Longterm Investment, Biotechs & High Yield Dividend Stocks ... #board-11828

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent ASM News
More ASM News